Live attenuated vaccines are vaccines made from killed pathogens.
This report aims to provide a comprehensive presentation of the global market for Live Attenuated Vaccines for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Vaccines for Pets. This report contains market size and forecasts of Live Attenuated Vaccines for Pets in global, including the following market information:
Global Live Attenuated Vaccines for Pets Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Live Attenuated Vaccines for Pets Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Live Attenuated Vaccines for Pets companies in 2022 (%)
The global Live Attenuated Vaccines for Pets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Virus Attenuated Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Live Attenuated Vaccines for Pets include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Live Attenuated Vaccines for Pets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Attenuated Vaccines for Pets Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, by Type, 2022 (%)
Virus Attenuated Vaccine
Bacterial Attenuated Vaccine
Global Live Attenuated Vaccines for Pets Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Dird
Others
Global Live Attenuated Vaccines for Pets Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Attenuated Vaccines for Pets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live Attenuated Vaccines for Pets revenues share in global market, 2022 (%)
Key companies Live Attenuated Vaccines for Pets sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Live Attenuated Vaccines for Pets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Live Attenuated Vaccines for Pets, market overview.
Chapter 2: Global Live Attenuated Vaccines for Pets market size in revenue and volume.
Chapter 3: Detailed analysis of Live Attenuated Vaccines for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Live Attenuated Vaccines for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Live Attenuated Vaccines for Pets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Live Attenuated Vaccines for Pets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Attenuated Vaccines for Pets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Attenuated Vaccines for Pets Overall Market Size
2.1 Global Live Attenuated Vaccines for Pets Market Size: 2022 VS 2029
2.2 Global Live Attenuated Vaccines for Pets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Live Attenuated Vaccines for Pets Sales: 2018-2029
3 Company Landscape
3.1 Top Live Attenuated Vaccines for Pets Players in Global Market
3.2 Top Global Live Attenuated Vaccines for Pets Companies Ranked by Revenue
3.3 Global Live Attenuated Vaccines for Pets Revenue by Companies
3.4 Global Live Attenuated Vaccines for Pets Sales by Companies
3.5 Global Live Attenuated Vaccines for Pets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live Attenuated Vaccines for Pets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live Attenuated Vaccines for Pets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Attenuated Vaccines for Pets Players in Global Market
3.8.1 List of Global Tier 1 Live Attenuated Vaccines for Pets Companies
3.8.2 List of Global Tier 2 and Tier 3 Live Attenuated Vaccines for Pets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live Attenuated Vaccines for Pets Market Size Markets, 2022 & 2029
4.1.2 Virus Attenuated Vaccine
4.1.3 Bacterial Attenuated Vaccine
4.2 By Type - Global Live Attenuated Vaccines for Pets Revenue & Forecasts
4.2.1 By Type - Global Live Attenuated Vaccines for Pets Revenue, 2018-2023
4.2.2 By Type - Global Live Attenuated Vaccines for Pets Revenue, 2024-2029
4.2.3 By Type - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
4.3 By Type - Global Live Attenuated Vaccines for Pets Sales & Forecasts
4.3.1 By Type - Global Live Attenuated Vaccines for Pets Sales, 2018-2023
4.3.2 By Type - Global Live Attenuated Vaccines for Pets Sales, 2024-2029
4.3.3 By Type - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
4.4 By Type - Global Live Attenuated Vaccines for Pets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live Attenuated Vaccines for Pets Market Size, 2022 & 2029
5.1.2 Dog
5.1.3 Cat
5.1.4 Dird
5.1.5 Others
5.2 By Application - Global Live Attenuated Vaccines for Pets Revenue & Forecasts
5.2.1 By Application - Global Live Attenuated Vaccines for Pets Revenue, 2018-2023
5.2.2 By Application - Global Live Attenuated Vaccines for Pets Revenue, 2024-2029
5.2.3 By Application - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
5.3 By Application - Global Live Attenuated Vaccines for Pets Sales & Forecasts
5.3.1 By Application - Global Live Attenuated Vaccines for Pets Sales, 2018-2023
5.3.2 By Application - Global Live Attenuated Vaccines for Pets Sales, 2024-2029
5.3.3 By Application - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
5.4 By Application - Global Live Attenuated Vaccines for Pets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Live Attenuated Vaccines for Pets Market Size, 2022 & 2029
6.2 By Region - Global Live Attenuated Vaccines for Pets Revenue & Forecasts
6.2.1 By Region - Global Live Attenuated Vaccines for Pets Revenue, 2018-2023
6.2.2 By Region - Global Live Attenuated Vaccines for Pets Revenue, 2024-2029
6.2.3 By Region - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
6.3 By Region - Global Live Attenuated Vaccines for Pets Sales & Forecasts
6.3.1 By Region - Global Live Attenuated Vaccines for Pets Sales, 2018-2023
6.3.2 By Region - Global Live Attenuated Vaccines for Pets Sales, 2024-2029
6.3.3 By Region - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Live Attenuated Vaccines for Pets Revenue, 2018-2029
6.4.2 By Country - North America Live Attenuated Vaccines for Pets Sales, 2018-2029
6.4.3 US Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.4.4 Canada Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.4.5 Mexico Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Live Attenuated Vaccines for Pets Revenue, 2018-2029
6.5.2 By Country - Europe Live Attenuated Vaccines for Pets Sales, 2018-2029
6.5.3 Germany Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.5.4 France Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.5.5 U.K. Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.5.6 Italy Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.5.7 Russia Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.5.8 Nordic Countries Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.5.9 Benelux Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Live Attenuated Vaccines for Pets Revenue, 2018-2029
6.6.2 By Region - Asia Live Attenuated Vaccines for Pets Sales, 2018-2029
6.6.3 China Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.6.4 Japan Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.6.5 South Korea Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.6.6 Southeast Asia Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.6.7 India Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Live Attenuated Vaccines for Pets Revenue, 2018-2029
6.7.2 By Country - South America Live Attenuated Vaccines for Pets Sales, 2018-2029
6.7.3 Brazil Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.7.4 Argentina Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales, 2018-2029
6.8.3 Turkey Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.8.4 Israel Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.8.5 Saudi Arabia Live Attenuated Vaccines for Pets Market Size, 2018-2029
6.8.6 UAE Live Attenuated Vaccines for Pets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Company Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Live Attenuated Vaccines for Pets Major Product Offerings
7.1.4 Bayer Healthcare Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Healthcare Key News & Latest Developments
7.2 Vetoquinol S.A
7.2.1 Vetoquinol S.A Company Summary
7.2.2 Vetoquinol S.A Business Overview
7.2.3 Vetoquinol S.A Live Attenuated Vaccines for Pets Major Product Offerings
7.2.4 Vetoquinol S.A Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.2.5 Vetoquinol S.A Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Live Attenuated Vaccines for Pets Major Product Offerings
7.3.4 Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Ceva
7.4.1 Ceva Company Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Live Attenuated Vaccines for Pets Major Product Offerings
7.4.4 Ceva Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Live Attenuated Vaccines for Pets Major Product Offerings
7.5.4 Eli Lilly Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 Heska
7.6.1 Heska Company Summary
7.6.2 Heska Business Overview
7.6.3 Heska Live Attenuated Vaccines for Pets Major Product Offerings
7.6.4 Heska Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.6.5 Heska Key News & Latest Developments
7.7 Merck Animal Health
7.7.1 Merck Animal Health Company Summary
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Live Attenuated Vaccines for Pets Major Product Offerings
7.7.4 Merck Animal Health Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.7.5 Merck Animal Health Key News & Latest Developments
7.8 Merial (Sanofi)
7.8.1 Merial (Sanofi) Company Summary
7.8.2 Merial (Sanofi) Business Overview
7.8.3 Merial (Sanofi) Live Attenuated Vaccines for Pets Major Product Offerings
7.8.4 Merial (Sanofi) Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.8.5 Merial (Sanofi) Key News & Latest Developments
7.9 Virbac
7.9.1 Virbac Company Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Live Attenuated Vaccines for Pets Major Product Offerings
7.9.4 Virbac Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.9.5 Virbac Key News & Latest Developments
7.10 Zoetis (Pfizer)
7.10.1 Zoetis (Pfizer) Company Summary
7.10.2 Zoetis (Pfizer) Business Overview
7.10.3 Zoetis (Pfizer) Live Attenuated Vaccines for Pets Major Product Offerings
7.10.4 Zoetis (Pfizer) Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.10.5 Zoetis (Pfizer) Key News & Latest Developments
8 Global Live Attenuated Vaccines for Pets Production Capacity, Analysis
8.1 Global Live Attenuated Vaccines for Pets Production Capacity, 2018-2029
8.2 Live Attenuated Vaccines for Pets Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Attenuated Vaccines for Pets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live Attenuated Vaccines for Pets Supply Chain Analysis
10.1 Live Attenuated Vaccines for Pets Industry Value Chain
10.2 Live Attenuated Vaccines for Pets Upstream Market
10.3 Live Attenuated Vaccines for Pets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live Attenuated Vaccines for Pets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Live Attenuated Vaccines for Pets in Global Market
Table 2. Top Live Attenuated Vaccines for Pets Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Live Attenuated Vaccines for Pets Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Live Attenuated Vaccines for Pets Revenue Share by Companies, 2018-2023
Table 5. Global Live Attenuated Vaccines for Pets Sales by Companies, (K Units), 2018-2023
Table 6. Global Live Attenuated Vaccines for Pets Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Live Attenuated Vaccines for Pets Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Live Attenuated Vaccines for Pets Product Type
Table 9. List of Global Tier 1 Live Attenuated Vaccines for Pets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Live Attenuated Vaccines for Pets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Live Attenuated Vaccines for Pets Sales (K Units), 2018-2023
Table 15. By Type - Global Live Attenuated Vaccines for Pets Sales (K Units), 2024-2029
Table 16. By Application ? Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Live Attenuated Vaccines for Pets Sales (K Units), 2018-2023
Table 20. By Application - Global Live Attenuated Vaccines for Pets Sales (K Units), 2024-2029
Table 21. By Region ? Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Live Attenuated Vaccines for Pets Sales (K Units), 2018-2023
Table 25. By Region - Global Live Attenuated Vaccines for Pets Sales (K Units), 2024-2029
Table 26. By Country - North America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 29. By Country - North America Live Attenuated Vaccines for Pets Sales, (K Units), 2024-2029
Table 30. By Country - Europe Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 33. By Country - Europe Live Attenuated Vaccines for Pets Sales, (K Units), 2024-2029
Table 34. By Region - Asia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 37. By Region - Asia Live Attenuated Vaccines for Pets Sales, (K Units), 2024-2029
Table 38. By Country - South America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 41. By Country - South America Live Attenuated Vaccines for Pets Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales, (K Units), 2024-2029
Table 46. Bayer Healthcare Company Summary
Table 47. Bayer Healthcare Live Attenuated Vaccines for Pets Product Offerings
Table 48. Bayer Healthcare Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bayer Healthcare Key News & Latest Developments
Table 50. Vetoquinol S.A Company Summary
Table 51. Vetoquinol S.A Live Attenuated Vaccines for Pets Product Offerings
Table 52. Vetoquinol S.A Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Vetoquinol S.A Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Live Attenuated Vaccines for Pets Product Offerings
Table 56. Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Ceva Company Summary
Table 59. Ceva Live Attenuated Vaccines for Pets Product Offerings
Table 60. Ceva Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Ceva Key News & Latest Developments
Table 62. Eli Lilly Company Summary
Table 63. Eli Lilly Live Attenuated Vaccines for Pets Product Offerings
Table 64. Eli Lilly Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Eli Lilly Key News & Latest Developments
Table 66. Heska Company Summary
Table 67. Heska Live Attenuated Vaccines for Pets Product Offerings
Table 68. Heska Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Heska Key News & Latest Developments
Table 70. Merck Animal Health Company Summary
Table 71. Merck Animal Health Live Attenuated Vaccines for Pets Product Offerings
Table 72. Merck Animal Health Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Merck Animal Health Key News & Latest Developments
Table 74. Merial (Sanofi) Company Summary
Table 75. Merial (Sanofi) Live Attenuated Vaccines for Pets Product Offerings
Table 76. Merial (Sanofi) Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Merial (Sanofi) Key News & Latest Developments
Table 78. Virbac Company Summary
Table 79. Virbac Live Attenuated Vaccines for Pets Product Offerings
Table 80. Virbac Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Virbac Key News & Latest Developments
Table 82. Zoetis (Pfizer) Company Summary
Table 83. Zoetis (Pfizer) Live Attenuated Vaccines for Pets Product Offerings
Table 84. Zoetis (Pfizer) Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Zoetis (Pfizer) Key News & Latest Developments
Table 86. Live Attenuated Vaccines for Pets Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Live Attenuated Vaccines for Pets Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Live Attenuated Vaccines for Pets Production by Region, 2018-2023 (K Units)
Table 89. Global Live Attenuated Vaccines for Pets Production by Region, 2024-2029 (K Units)
Table 90. Live Attenuated Vaccines for Pets Market Opportunities & Trends in Global Market
Table 91. Live Attenuated Vaccines for Pets Market Drivers in Global Market
Table 92. Live Attenuated Vaccines for Pets Market Restraints in Global Market
Table 93. Live Attenuated Vaccines for Pets Raw Materials
Table 94. Live Attenuated Vaccines for Pets Raw Materials Suppliers in Global Market
Table 95. Typical Live Attenuated Vaccines for Pets Downstream
Table 96. Live Attenuated Vaccines for Pets Downstream Clients in Global Market
Table 97. Live Attenuated Vaccines for Pets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Live Attenuated Vaccines for Pets Segment by Type in 2022
Figure 2. Live Attenuated Vaccines for Pets Segment by Application in 2022
Figure 3. Global Live Attenuated Vaccines for Pets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Live Attenuated Vaccines for Pets Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Live Attenuated Vaccines for Pets Revenue, 2018-2029 (US$, Mn)
Figure 7. Live Attenuated Vaccines for Pets Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Live Attenuated Vaccines for Pets Revenue in 2022
Figure 9. By Type - Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 11. By Type - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 12. By Type - Global Live Attenuated Vaccines for Pets Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 15. By Application - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 16. By Application - Global Live Attenuated Vaccines for Pets Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 20. By Region - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 21. By Country - North America Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 22. By Country - North America Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 23. US Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 28. Germany Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 29. France Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 37. China Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 41. India Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 43. By Country - South America Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 44. Brazil Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales Market Share, 2018-2029
Figure 48. Turkey Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2029
Figure 52. Global Live Attenuated Vaccines for Pets Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Live Attenuated Vaccines for Pets by Region, 2022 VS 2029
Figure 54. Live Attenuated Vaccines for Pets Industry Value Chain
Figure 55. Marketing Channels
